The Journal of Emergency Medicine
Volume 37, Issue 4 , Pages 369-375 , November 2009

Nitroglycerin and Epinephrine Improve Coronary Perfusion Pressure in a Porcine Model of Ventricular Fibrillation Arrest: A Pilot Study

Received 24 January 2008 ,Revised 27 June 2008 ,Accepted 1 July 2008.

References 

  1. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe (Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe). Eur Heart J. 1997;18:1231–1248
  2. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In:  Braunwald E,  Zipes DB,  Libby P editor. Heart disease: a textbook of cardiovascular medicine. 6th edn.. Philapelphia, PA: WB Saunders; 2001;p. 890–931
  3. Athanasuleas CL, Buckberg GD, Allen BS, Beyersdorf F, Kirsh MM. Sudden cardiac death: directing the scope of resuscitation towards the heart and brain. Resuscitation. 2002;70:44–51
  4. Nolan JP, Deakin CD, Soar J, Bottiger BW, Smith G. European Resuscitation Council Guidelines for Resuscitation 2005 (Section 4. adult advanced life support). Resuscitation. 2005;67S1:S39–S86
  5. Hollenberg SM. Vasodilators in acute heart failure. Heart Fail Rev. 2007;12:143–147
  6. Xanthos T, Lelovas P, Vlachos I, et al. Carpiopulmonary arrest and resuscitation in Landrace/Large White swine: a research model. Lab Anim. 2007;41:353–362
  7. Frennaux M. Cardiopulmonary resuscitation-some physiological considerations. Resuscitation. 2003;58:259–265
  8. Hong MF, Dorian P. Update on advanced life support and resuscitation techniques [arrhythmias]. Curr Opin Cardiol. 2005;20:1–6
  9. Varon J, Manik PE, Fronn RE. Cardiopulmonary resuscitation: a review for clinicians. Resuscitation. 1998;36:133–145
  10. Otto CW, Yakaitis RW. The role of epinephrine in CPR: a reappraisal. Ann Emerg Med. 1984;13:840–843
  11. Grmec S, Mally S. Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: an observational cohort study. Crit Care. 2006;10:R13
  12. Lei H, Tang W. Vasopressor agents: old and new components. Curr Opin Crit Care. 2004;10:183–187
  13. Paradis NA, Martin GP, Rivers EP, et al. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA. 1990;263:1106–1113
  14. Murrel W. Nitro-glycerine as a remedy for angina pectoris. Lancet. 1879;1:80–81
  15. Kleschyov AL, Oelze M, Daiber A, et al. Does nitric oxide mediate the vasodilator activity of nitroglycerin?. Circ Res. 2003;93:e104–e112
  16. Harrison DG, Bates JN. The nitrovasodilators new ideas about old drugs. Circulation. 1993;87:1461–1467
  17. Wenzel V, Lindner KH, Mayer H, Lurie KG, Prengel AW. Vasopressin combined with nitroglycerin increases endocardial perfusion during cardiopulmonary resuscitation in pigs. Resuscitation. 1998;38:13–17
  18. Bache RJ. Effect of nitroglycerin and arterial hypertension on myocardial blood flow following acute coronary occlusion in the dog. Circulation. 1978;57:557–562
  19. Brazzamono S, Mays AE, Rembert JC, et al. Increase in collateral blood flow following repeated coronary artery occlusion and nitroglycerin administration. Circ Res. 1984;54:204–207
  20. Kono S, Suzuki A, Obata Y, Igarashi H, Bito H, Sato S. Vasopressin with delayed combination of nitroglycerin increases survival rate in asphyxia rat model. Resuscitation. 2002;54:297–301
  21. Pellis T, Weil MH, Tang W, et al. Evidence favoring the use of an α2-selective vasopressor agent for cardiopulmonary resuscitation. Circulation. 2003;108:2716–2721
  22. Robinson LA, Brown CG, Jenkins J, Van Ligten PF, Werman H, Ashton J. The effect of norepinephrine versus epinephrine on myocardial hemodynamics during CPR. Ann Emerg Med. 1989;18:336–340
  23. Lurie KG, Voeckel WG, Iskos DN, McKnite SH, Zielinski TM, Sugiyama A. Combination drug therapy with vasopressin, adrenaline (epinephrine) and nitroglycerin improves vital organ blood flow in a porcine model of ventricular fibrillation. Resuscitation. 2002;54:187–194
  24. Osada M, Tanaka Y, Komai T, Maeda Y, Kitano M, Oishi M. Successful resuscitation using nitroglycerin for refractory pulseless electrical activity in intensive care unit. Intensive Care Med. 2000;26:255
  25. Spronk PE, Ince C, Gardien J, Mathura KR, Oudemans-van-Straaten HM, Zandstra DF. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet. 2002;360:1395–1396
  26. Nakajima Y, Baudry N, Duranteau J, Vicaut E. Effects of vasopressin, norepinephrine, and L-arginine on intestinal microcirculation in endotoxemia. Crit Care Med. 2006;34:1752–1757
  27. Zhao SX, Lee LM, Nearing BD, Busso V, Kwaku KF, Verrier RL. Suppression of calcium-induced repolarisation heterogeneity as a mechanism of nitroglycerin antiarrhythmic action. J Cardiovasc Pharmacol. 2006;48:22–29
  28. Massion PB, Feron O, Dessy C, Balligand JL. Nitric oxide and cardiac function (Ten years after, and continuing). Circ Res. 2003;93:388–398
  29. Cohen RA, Weibrod RM, Gericke M, et al. Mechanism of nitric oxide induced vasodilatation: refilling of intracellular stores by sarcoplasmic reticulum Ca2+ATPase and inhibition of store-operated Ca2+ influx. Circ Res. 1999;84:210–219

 This project was co-financed with Op. Education by ESF (European Social Fund) and National Resources EPEAK II-Pythagoras II.

PII: S0736-4679(08)00673-2

doi: 10.1016/j.jemermed.2008.07.003

The Journal of Emergency Medicine
Volume 37, Issue 4 , Pages 369-375 , November 2009

Article Tools

* Image Usage & Resolution